Results 111 to 120 of about 46,982 (194)

B7-H3 membranous expression correlates with histological grading in a two-center cohort of 133 pre-treatment bone and soft tissue sarcoma samples. [PDF]

BMC Cancer
Kloker LD, Rottscholl R, Heitmann JS, Bronsert P, Braig D, Benzler K, Zender L, Deinzer CKW.   +7 more
europepmc   +1 more source

Igniting cold tumors: reprogramming the tumor immune microenvironment with dual-payload ADCs in combination with PD-L1&4-1BB bispecific antibodies. [PDF]

J Immunother Cancer
Pan J, Yuan X, Yu H, Liu Z, Chen S, Zhu F, Shang Y, Hong S, Han X, Zhu Z, Jin T, Pan Y, Zhou S.   +12 more
europepmc   +1 more source

Targeting B7-H3 in patients with metastatic triple-negative breast cancer and brain metastases: an opportunity to "revive" immunotherapy as a treatment strategy? [PDF]

J Immunother Cancer
Kojundzic I, Zatzman C, Belone Lopes J, Ramay R, Bayani J, Spears M, Jerzak KJ.   +6 more
europepmc   +1 more source

Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine glioma. [PDF]

Neuro Oncol
Timpanaro A, Song EZ, Toumi R, Elena-Sanchez L, Piccand C, Nemec KM, Kordowski A, Lau D, Johnson S, Winter L, Rajendran A, Ronsley R, Oda SK, Gustafson JA, Wendler JP, Koschmann C, Evans M, Pattwell S, Jensen MC, Foster JB, Dun MD, Meechan M, Biery MC, Vitanza NA.   +23 more
europepmc   +1 more source

Multiple sclerosis-associated HLA demarcates EBV-specific CD8⁺ T cells with an exhausted and brain residency phenotype. [PDF]

iScience
Reijm S, Marques AM, Rip J, Corsten CEA, Wierenga-Wolf AF, de Wit H, Melief MJ, van Hasselt Y, van Langelaar J, Neuteboom R, Wokke BHA, Mueller YM, Smolders J, van Luijn MM.   +13 more
europepmc   +1 more source

Immune checkpoint inhibitors in medulloblastoma: current updates in preclinical and clinical developments. [PDF]

Front Oncol
Welch RL, Moziak K, Zang X, Martin AM.
europepmc   +1 more source

Harnessing γδ T cells for B7-H3-targeting CAR therapy to enhance anti-tumor therapy in glioblastoma. [PDF]

J Transl Med
Wu H, Chen T, Yu Y, Zhu S.
europepmc   +1 more source

From mechanism to clinical: research evolution and hotspot analysis of CD276/B7-H3 in cancer immunotherapy. [PDF]

Front Immunol
Zhai C, Ye J, Li X, Liu J, Zhou X, Wang Z, Zhang X, Zeng W, Luo H, Chen L, Zhou F.   +10 more
europepmc   +1 more source

Prognostic and therapeutic roles of B7-H3 and B7-H4 in prostate cancer. [PDF]

Discov Oncol
Hu Y, Yang W, Guo S, Huang D.
europepmc   +1 more source

Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy. [PDF]

Exp Hematol Oncol
Riet T, Lennartz S, Bösing N, Prinz LF, Dähn L, Scheid C, Hallek M, Chmielewski MM.   +7 more
europepmc   +1 more source